Browsing byAuthorKatari, NK
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
| 2022-01-01 | One-step synthesis of picolinohydrazides from fusaric acid: DFT, structural characterization and molecular inhibitory studies on metastatic tumor-derived exosomal and non-exosomal proteins | Anand, K; Ramesh, M; Singh, T; Balakumar, C; Chithravel, V; Prasher, P; Katari, NK; Gupta, G; Singh, SK; Chellappan, DK; Dua, K; Chavda, V; Laishevtcev, A; Shahbaaz, M; Abdellattif, MH; Saravanan, M; Chuturgoon, AA |
| 2021-10 | Peptides-based therapeutics: emerging potential therapeutic agents for COVID-19 | Shah, JN; Guo, G-Q; Krishnan, A; Ramesh, M; Katari, NK; Shahbaaz, M; Abdellattif, MH; Singh, SK; Dua, K |
| 2021-02-24 | An overview of vaccine development for COVID-19 | Shahcheraghi, SH; Ayatollahi, J; Aljabali, AA; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Katari, NK; Mehta, M; Satija, S; Dureja, H; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Gupta, G; Dua, K; Lotfi, M; Bakshi, HA; Tambuwala, MM |
| 2021 | <i>In vitro</i> Dissolution Profile at Different Biological pH Conditions of Hydroxychloroquine Sulfate Tablets Is Available for the Treatment of COVID-19. | Dongala, T; Katari, NK; Ettaboina, SK; Krishnan, A; Tambuwala, MM; Dua, K |
